Asarfi Hospital

What does Asarfi Hospital do?

Asarfi Hospital Ltd is a micro-cap company in the hospital industry, incorporated in 2005 and converted to a public limited company in 2012. As of March 2025, it reported net sales of 34 Cr and a net profit of 4 Cr, with a market cap of Rs 268 Cr.

Overview: <BR>Asarfi Hospital Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Asarfi Hospital Limited was originally incorporated as a Private Limited Company on October 4, 2005, under the name "Asarfi Hospital Private Limited." The company later converted its status to Public Limited and changed its name to "Asarfi Hospital Limited" on February 08, 2012. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 34 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 4 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 268 Cr (Micro Cap) <BR><BR>Key Metrics: <BR>P/E: 24.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.20 <BR>Return on Equity: 15.58% <BR>Price to Book: 3.76 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Has Asarfi Hospital declared dividend?

No Dividend History Available

What is the technical trend for Asarfi Hospital?

As of May 19, 2025, Asarfi Hospital's technical trend is bullish, supported by a positive MACD and moving averages, although the weekly RSI indicates some potential weakness in momentum.

As of 19 May 2025, the technical trend for Asarfi Hospital has changed from mildly bullish to bullish. The weekly MACD is bullish, supporting the positive trend, while the daily moving averages also indicate bullish momentum. The Bollinger Bands are bullish on both weekly and monthly time frames, reinforcing the strength of the current trend. However, the weekly RSI is bearish, suggesting some potential weakness in momentum. Dow Theory indicates a mildly bullish stance on both weekly and monthly time frames. Overall, the current technical stance is bullish with moderate strength, driven primarily by the bullish MACD and moving averages.

Who are the peers of the Asarfi Hospital?

Asarfi Hospital's peers include GPT Healthcare, KMC Speciality, Aashka Hospitals, and others, with varying management risks and growth rates. Asarfi Hospital has a good management risk and a 1-year return of 92.36%, outperforming its peers.

Peers: The peers of Asarfi Hospital are GPT Healthcare, KMC Speciality, Abate As Indust, Aashka Hospitals, Aprameya Enginee, Unihealth Hosp, Chandan Healthca, Nephro Care, KHFM Hospitality, and Maitreya Medica.<BR><BR>Quality Snapshot: Excellent management risk is observed at GPT Healthcare and Chandan Healthca, while Average management risk is found at KMC Speciality and KHFM Hospitality. Good management risk is noted at Asarfi Hospital, Aprameya Enginee, Unihealth Hosp, and Nephro Care, while Below Average management risk is present at Aashka Hospitals. Growth is Excellent at Aprameya Enginee and Nephro Care, Below Average at GPT Healthcare, KMC Speciality, Asarfi Hospital, Aashka Hospitals, and KHFM Hospitality, and does not qualify for Abate As Indust. Capital Structure is Excellent at GPT Healthcare and KMC Speciality, Good at Asarfi Hospital, Nephro Care, and Chandan Healthca, Below Average at Aprameya Enginee, Unihealth Hosp, Aashka Hospitals, and KHFM Hospitality, and does not qualify for Abate As Indust.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Abate As Indust at 46.07%, while the lowest is KMC Speciality at -19.73%. Asarfi Hospital's 1-year return is 92.36%, which is significantly higher than both. Additionally, KMC Speciality, Aashka Hospitals, and KHFM Hospitality have negative six-month returns.

Who are in the management team of Asarfi Hospital?

As of March 2023, the management team of Asarfi Hospital includes Udai Pratap Singh (Managing Director), Madhuri Singh (Executive Director), Sukanti Kumar Das (Director), Amit Kumar Barnwal (Independent Director), Rajkumari Sharma (Independent Director), and Seepika Gupta (Company Secretary & Compliance Officer). Each member contributes to the hospital's governance and operations.

As of March 2023, the management team of Asarfi Hospital includes the following individuals:<BR><BR>1. Udai Pratap Singh - Managing Director<BR>2. Madhuri Singh - Executive Director<BR>3. Sukanti Kumar Das - Director<BR>4. Amit Kumar Barnwal - Independent Director<BR>5. Rajkumari Sharma - Independent Director<BR>6. Seepika Gupta - Company Secretary & Compliance Officer<BR><BR>Each member plays a crucial role in the governance and operational oversight of the hospital.

Who are the top shareholders of the Asarfi Hospital?

The top shareholders of Asarfi Hospital include Harendra Singh with 18.78%, followed by public shareholder Gopal Singh at 2.4%. Individual investors collectively own 30.86% of the shares, with no pledged promoter holdings or involvement from mutual funds or foreign institutional investors.

The top shareholders of Asarfi Hospital primarily consist of the promoters, with Harendra Singh holding the largest stake at 18.78%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors involved. The highest public shareholder is Gopal Singh, who holds 2.4%. Additionally, individual investors collectively own 30.86% of the shares.

How big is Asarfi Hospital?

As of 24th July, Asarfi Hospital Ltd has a market capitalization of 261.00 Cr, with net sales of 110.87 Cr and a net profit of 6.01 Cr over the last four quarters. Shareholder's funds are 70.41 Cr, and total assets amount to 154.09 Cr as of March 2024.

As of 24th July, <BR><BR>Market Cap: Asarfi Hospital Ltd has a market capitalization of 261.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 110.87 Cr, while the sum of Net Profit for the same period is 6.01 Cr.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2024. Shareholder's Funds stand at 70.41 Cr, and Total Assets amount to 154.09 Cr.

How has been the historical performance of Asarfi Hospital?

Asarfi Hospital experienced significant growth in net sales and profits from Mar'24 to Mar'25, with net sales rising to 120.57 Cr and profit after tax increasing to 10.58 Cr. However, cash flow from operating activities turned negative, indicating challenges in cash management despite strong revenue performance.

Answer:<BR>The historical performance of Asarfi Hospital shows significant growth from the previous year, with net sales increasing from 84.40 Cr in Mar'24 to 120.57 Cr in Mar'25. Total operating income mirrored this growth, rising to 120.57 Cr from 84.40 Cr. The total expenditure also increased, from 68.35 Cr to 97.01 Cr, primarily driven by higher raw material costs and other expenses. Operating profit (PBDIT) rose to 31.08 Cr from 17.72 Cr, while profit before tax improved from 6.24 Cr to 14.31 Cr. Consequently, profit after tax saw a substantial increase from 4.16 Cr to 10.58 Cr, resulting in an earnings per share (EPS) growth from 2.11 to 5.38. <BR><BR>In terms of balance sheet performance, shareholder's funds increased to 80.98 Cr from 70.41 Cr, and total liabilities rose to 163.89 Cr from 154.09 Cr. Long-term borrowings also increased significantly from 17.45 Cr to 33.83 Cr. Current assets improved to 58.48 Cr from 45.60 Cr, with notable increases in sundry debtors and inventories. However, cash flow from operating activities turned negative, dropping from 26.00 Cr to -4.00 Cr, while cash flow from financing activities decreased from 36.00 Cr to 12.00 Cr. Overall, Asarfi Hospital demonstrated strong revenue and profit growth, despite challenges in cash flow management.

Is Asarfi Hospital overvalued or undervalued?

As of November 14, 2025, Asarfi Hospital is considered overvalued with a PE ratio of 31.38 and an EV to EBITDA of 16.34, despite strong stock performance, indicating it may not be an attractive investment compared to peers like Apollo Hospitals and Max Healthcare.

As of 14 November 2025, Asarfi Hospital's valuation grade has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as overvalued. Key ratios include a PE ratio of 31.38, an EV to EBITDA of 16.34, and a PEG ratio of 0.20, which suggests growth potential relative to its valuation. <BR><BR>In comparison to peers, Apollo Hospitals has a significantly higher PE ratio of 63.77 and an EV to EBITDA of 33.53, while Max Healthcare is marked as very expensive with a PE of 89.07. Despite the recent strong stock performance, with a year-to-date return of 75.1% compared to the Sensex's 8.22%, the elevated valuation metrics indicate that Asarfi Hospital may not present an attractive investment opportunity at current levels.

When is the next results date for Asarfi Hospital Ltd?

The next results date for Asarfi Hospital Ltd is 09 February 2026.

The next results date for Asarfi Hospital Ltd is scheduled for 09 February 2026.

Are Asarfi Hospital Ltd latest results good or bad?

Asarfi Hospital Ltd's latest Q3 FY26 results are strong, with a net profit of ₹5.42 crores, up 102.24% year-on-year, and revenue growth of 40.16% to ₹46.10 crores. The company has improved its operating and PAT margins, indicating robust operational efficiency and positioning it well in the healthcare sector.

Asarfi Hospital Ltd's latest results for Q3 FY26 are quite strong and indicate a positive performance. The company reported a net profit of ₹5.42 crores, which is a remarkable increase of 102.24% year-on-year. Additionally, revenue for the same quarter reached ₹46.10 crores, reflecting a growth of 40.16% compared to the previous year.<BR><BR>The operating margin also improved, reaching 21.93%, the highest in seven quarters, and the PAT margin increased to 11.76%, up by 361 basis points year-on-year. This demonstrates the company's ability to enhance operational efficiency while scaling its operations.<BR><BR>Overall, the financial performance showcases impressive growth and operational excellence, positioning Asarfi Hospital as a strong player in the healthcare sector. The stock has also performed exceptionally well, significantly outperforming the broader market and its peers over the past year.

Which are the latest news on Asarfi Hospital?

Should I buy, sell or hold Asarfi Hospital Ltd?

Why is Asarfi Hospital Ltd falling/rising?

As of 17-Mar, Asarfi Hospital Ltd's stock price is declining, currently at 151.95, down 2.6% and underperforming its sector. The stock has shown significant volatility and is trading below all major moving averages, indicating a bearish trend and decreased investor confidence.

As of 17-Mar, Asarfi Hospital Ltd's stock price is falling, currently at 151.95, which reflects a decrease of 4.05 or 2.6%. The stock has underperformed its sector by 3.15% today. Over the past week, the stock has declined by 6.49%, while the benchmark Sensex has only fallen by 2.73%. In the last month, the stock has dropped 10.83%, compared to an 8.84% decline in the Sensex.<BR><BR>Today's trading session saw the stock reach a high of Rs 160, but it also hit a low of Rs 149.95, indicating significant volatility. The weighted average price suggests that more volume was traded closer to the low price, which is a bearish signal. Additionally, Asarfi Hospital is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further indicating a downward trend.<BR><BR>Investor participation has also decreased, with delivery volume on 16 March falling by 35.67% compared to the 5-day average. This decline in trading activity suggests a lack of confidence among investors, contributing to the stock's downward movement. Overall, these factors collectively explain why Asarfi Hospital Ltd's stock price is currently falling.

Why is Asarfi Hospital Ltd falling/rising?

As of 18-Mar, Asarfi Hospital Ltd's stock price is rising to Rs 162.00, up 7.36%, driven by strong financial performance and significant net profit growth. The stock has outperformed its sector and generated a remarkable 99.48% return over the past year, indicating strong investor confidence.

As of 18-Mar, Asarfi Hospital Ltd's stock price is rising, currently at Rs 162.00, reflecting an increase of Rs 11.1 or 7.36%. This rise can be attributed to several positive factors. Notably, the company has demonstrated strong financial performance, with a significant growth in net profit of 29.05% and outstanding results over the last three consecutive quarters. The stock has also outperformed its sector by 6.06% today.<BR><BR>Additionally, the stock's performance over the past year has been remarkable, generating a return of 99.48%, which is substantially higher than the market's return of 5.49%. The company's low Debt to EBITDA ratio of 1.20 times indicates a strong ability to service its debt, further enhancing investor confidence. The rising investor participation, with a delivery volume increase of 8.33% against the 5-day average, also suggests growing interest in the stock.<BR><BR>Despite some negative factors, such as poor long-term growth in operating profit, the immediate performance indicators and strong financial results are driving the stock's upward movement.

Why is Asarfi Hospital Ltd falling/rising?

As of 19-Mar, Asarfi Hospital Ltd's stock price is currently at 157.00, reflecting a decline of 3.2 or 2.0%. The stock has underperformed recently, with a year-to-date drop of 16.53%, and is trading below key moving averages, indicating a bearish trend.

As of 19-Mar, Asarfi Hospital Ltd's stock price is falling, currently at 157.00, which reflects a decrease of 3.2 or 2.0%. The stock opened with a loss of 2% today and reached an intraday low of Rs 153, marking a decline of 4.49%. Over the past week, the stock has underperformed with a decline of 1.66%, while the benchmark Sensex fell by 2.40%. Additionally, the stock has shown a significant year-to-date decline of 16.53%, compared to a 12.92% drop in the Sensex. <BR><BR>Despite some positive indicators, such as outperforming the sector by 0.82% today and a notable increase in delivery volume by 129.59% against the 5-day average, the overall trend remains negative. The stock is trading lower than the 20-day, 50-day, and 100-day moving averages, which suggests a bearish sentiment. Furthermore, the broader sector of Hospital & Healthcare Services has also experienced a decline of 2.63%, contributing to the downward pressure on Asarfi Hospital Ltd's stock price.

Why is Asarfi Hospital Ltd falling/rising?

As of 20-Mar, Asarfi Hospital Ltd's stock price is rising to 161.00, driven by strong financial performance and significant investor interest. Despite a decrease in delivery volume, the stock has outperformed its sector and generated impressive returns over the past year.

As of 20-Mar, Asarfi Hospital Ltd's stock price is rising, currently at 161.00, reflecting a change of 3.85 (2.45%) upwards. This increase can be attributed to several positive factors. The stock has outperformed its sector by 1.89% today and opened with a gain of 2.13%. Additionally, it reached an intraday high of Rs 163, indicating strong investor interest.<BR><BR>The company's financial performance has been robust, with a significant growth in net profit of 29.05% and positive results declared for the last three consecutive quarters. Over the past year, the stock has generated an impressive return of 91.67%, significantly outperforming the market benchmark, which only returned 0.76%. The company's ability to service debt is also strong, evidenced by a low Debt to EBITDA ratio of 1.20 times, and it boasts a very attractive valuation with a PEG ratio of 0.1.<BR><BR>However, it is important to note that despite the current rise, there are concerns regarding falling investor participation, as the delivery volume has decreased by 60.94% compared to the 5-day average. This could indicate a potential risk for future price movements. Nonetheless, the current upward trend is supported by the company's strong financial results and market performance.

Why is Asarfi Hospital Ltd falling/rising?

As of 23-Mar, Asarfi Hospital Ltd's stock price is declining, currently at Rs 157.00, reflecting a 2.45% drop. This trend is influenced by broader market conditions and a significant decrease in investor participation.

As of 23-Mar, Asarfi Hospital Ltd's stock price is falling, currently at Rs 157.00, which reflects a decrease of Rs 3.95 or 2.45%. This decline is consistent with the overall performance of the Hospital & Healthcare Services sector, which has also experienced a drop of 2.37%. <BR><BR>In terms of recent performance, the stock has shown a negative trend over the past month, with a decrease of 4.68%, while the year-to-date performance indicates a significant decline of 16.53%. Additionally, the stock's performance today is inline with the sector, suggesting that broader market conditions are influencing its price movement. <BR><BR>Investor participation has also decreased, as evidenced by a 63.35% drop in delivery volume compared to the 5-day average, indicating reduced trading activity and interest in the stock. Furthermore, while the stock is trading above its 5-day and 200-day moving averages, it is below its 20-day, 50-day, and 100-day moving averages, which may signal a bearish trend. <BR><BR>Overall, the combination of sector performance, declining investor participation, and the stock's relative moving averages contribute to the observed decline in Asarfi Hospital Ltd's stock price.

Why is Asarfi Hospital Ltd falling/rising?

As of 24-Mar, Asarfi Hospital Ltd's stock price is at 165.00, reflecting a 4.96% increase. The stock has outperformed the Sensex and its sector, showing strong buying interest despite a decline in investor participation.

As of 24-Mar, Asarfi Hospital Ltd's stock price is rising, currently at 165.00, which reflects a change of 7.8 or 4.96% increase. This upward movement can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 9.34% while the Sensex declined by 2.63%. Additionally, the stock's performance today has outpaced its sector, with a gain of 2.61%. <BR><BR>The stock reached an intraday high of Rs 167, indicating strong buying interest, although it also saw a low of Rs 154. Despite the day's fluctuations, the overall trend remains positive. Furthermore, the stock is trading above its 5-day, 20-day, and 200-day moving averages, suggesting a bullish sentiment among investors, even though it is below the 50-day and 100-day moving averages.<BR><BR>However, it is important to note that there has been a decline in investor participation, with delivery volume falling by 32.43% compared to the 5-day average. Despite this, the stock remains liquid enough for trading, which may contribute to its price stability and gradual rise. Overall, the combination of recent performance, sector strength, and current trading conditions supports the stock's upward movement.

Why is Asarfi Hospital Ltd falling/rising?

As of 25-Mar, Asarfi Hospital Ltd's stock price is rising to 176.70, reflecting a 7.68% increase. This growth is driven by strong financial performance, increased investor participation, and positive market sentiment, with the stock outperforming its sector and showing significant gains over the past year.

As of 25-Mar, Asarfi Hospital Ltd's stock price is rising, currently at 176.70, reflecting an increase of 12.6 or 7.68%. This upward movement can be attributed to several factors. The stock has outperformed its sector by 5.41% today and has been on a consecutive gain streak for the last two days, accumulating a total return of 12.4% during this period. Additionally, the stock opened with a gain of 2.96% today and reached an intraday high of Rs 188.8, marking a 15.05% increase.<BR><BR>The stock's performance is further supported by its trading position above key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. There has also been a notable increase in investor participation, with delivery volume rising by 78.19% against the 5-day average. The overall market for the Hospital & Healthcare Services sector has gained by 2.27%, contributing to the positive sentiment around Asarfi Hospital Ltd.<BR><BR>Financially, the company has demonstrated strong results, with a 29.05% growth in net profit and positive results reported for the last three consecutive quarters. The stock has generated an impressive return of 105.80% over the past year, significantly outperforming the broader market, which has seen negative returns. This strong performance, coupled with a low Debt to EBITDA ratio and attractive valuation metrics, reinforces investor confidence, driving the stock price higher.